R&D Systems™ Human CXCL13/BLC/BCA-1 Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Marke: R&D Systems™ 801-CX-025/CF
Weitere Details : Netto-Gewicht : 0.00010kg
BeschreibungThe Recombinant Human CXCL13/BLC/BCA-1 Protein is derived from E. coli. The Recombinant Human CXCL13/BLC/BCA-1 Protein has been validated for the following applications: Bioactivity.
|Lyophilized from a 0.2μm filtered solution in Acetonitrile and TFA.|
|95%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|